Patents Assigned to Centre Internationnal de Recherche Aux Frontieres de la Chimie
  • Publication number: 20190062278
    Abstract: The present invention relates to hydroxychloroquine analogues having an activity superior to that of hydroxychloroquine but free from retinal cytotoxicity of formula (I), their pharmaceutically acceptable salts, solvates or hydrates: their method of preparation and their use in the treatment of lupus erythematosus.
    Type: Application
    Filed: June 6, 2016
    Publication date: February 28, 2019
    Applicants: Inoviem Scientific, Universite de Strasbourg, Centre National de la Recherche Scientifique (CNRS, Centre Internationnal de Recherche Aux Frontieres de la Chimie
    Inventors: Anne-Sophie Korganow, Pierre Eftekhari, Alain Wagner, Corinne Baehr